{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T02:55:23Z","timestamp":1793933723764,"version":"4.8.0"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,11,20]],"date-time":"2019-11-20T00:00:00Z","timestamp":1574208000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["autonomicneuroscience.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autonomic Neuroscience"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.autneu.2019.102590","type":"journal-article","created":{"date-parts":[[2019,10,23]],"date-time":"2019-10-23T02:00:38Z","timestamp":1571796038000},"page":"102590","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"special_numbering":"C","title":["Blood pressure and orthostatic hypotension as measures of autonomic dysfunction in patients from the transthyretin amyloidosis outcomes survey (THAOS)"],"prefix":"10.1016","volume":"222","author":[{"given":"Alejandra","family":"Gonz\u00e1lez-Duarte","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Barroso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajiv","family":"Mundayat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan","family":"Shapiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autneu.2019.102590_bb0005","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1750-1172-8-31","article-title":"Guideline of transthyretin-related hereditary amyloidosis for clinicians","volume":"8","author":"Ando","year":"2013","journal-title":"Orphanet. J. Rare Dis."},{"key":"10.1016\/j.autneu.2019.102590_bb0010","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1136\/bmj.322.7292.981","article-title":"ABC of hypertension. Blood pressure measurement. Part I-sphygmomanometry: factors common to all techniques","volume":"322","author":"Beevers","year":"2001","journal-title":"BMJ (Clinical research ed)"},{"key":"10.1016\/j.autneu.2019.102590_bb0015","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/mus.20821","article-title":"The molecular biology and clinical features of amyloid neuropathy","volume":"36","author":"Benson","year":"2007","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.autneu.2019.102590_bb0020","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s10741-014-9462-7","article-title":"Natural history and therapy of TTR-cardiac amyloidosis: emerging disease-modifying therapies from organ transplantation to stabilizer and silencer drugs","volume":"20","author":"Castano","year":"2015","journal-title":"Heart Fail. Rev."},{"key":"10.1016\/j.autneu.2019.102590_bb0025","article-title":"Blood pressure variability in a new life?","volume":"9","author":"Clement","year":"2011","journal-title":"E-J. Cardiol. Pract."},{"key":"10.1016\/j.autneu.2019.102590_bb0030","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1185\/03007995.2012.754348","article-title":"THAOS - the Transthyretin Amyloidosis Outcomes Survey: initial report on clinical manifestations in patients with hereditary and wild-type transthyretin amyloidosis","volume":"29","author":"Coelho","year":"2013","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.autneu.2019.102590_bb0035","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1161\/CIRCULATIONAHA.115.018852","article-title":"Heart failure resulting from age-related cardiac amyloid disease associated with wild-type transthyretin: a prospective, observational cohort study","volume":"133","author":"Connors","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.autneu.2019.102590_bb0040","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1161\/01.CIR.75.2.340","article-title":"The association of postural changes in systolic blood pressure and mortality in persons with hypertension: the Hypertension Detection and Follow-up program experience","volume":"75","author":"Davis","year":"1987","journal-title":"Circulation"},{"key":"10.1016\/j.autneu.2019.102590_bb0045","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1365-2702.2005.01494.x","article-title":"The effect of different body positions on blood pressure","volume":"16","author":"Eser","year":"2007","journal-title":"J. Clin. Nurs."},{"key":"10.1016\/j.autneu.2019.102590_bb0050","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s10286-011-0119-5","article-title":"Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome","volume":"21","author":"Freeman","year":"2011","journal-title":"Clin. Auton. Res."},{"key":"10.1016\/j.autneu.2019.102590_bb0055","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0025-6196(12)60388-7","article-title":"Familial amyloidosis: a study of 52 North American-born patients examined during a 30-year period","volume":"67","author":"Gertz","year":"1992","journal-title":"Mayo Clinic Proceedings Mayo Clinic"},{"key":"10.1016\/j.autneu.2019.102590_bb0060","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s10286-018-0514-2","article-title":"Autonomic involvement in hereditary transthyretin amyloidosis (hATTR amyloidosis)","volume":"29","author":"Gonzalez-Duarte","year":"2019","journal-title":"Clin. Auton. Res."},{"key":"10.1016\/j.autneu.2019.102590_bb0065","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.jacc.2016.06.033","article-title":"Natural history of wild-type transthyretin cardiac amyloidosis and risk stratification using a novel staging system","volume":"68","author":"Grogan","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.autneu.2019.102590_bb0070","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1001\/archneur.59.11.1771","article-title":"Type I (transthyretin Met30) familial amyloid polyneuropathy in Japan: early- vs late-onset form","volume":"59","author":"Koike","year":"2002","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.autneu.2019.102590_bb0075","series-title":"Cardiovascular Medicine","first-page":"1883","article-title":"Autonomic dysfunction and hypotension","author":"Mathias","year":"2007"},{"key":"10.1016\/j.autneu.2019.102590_bb0080","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jacc.2016.03.596","article-title":"Genotype and phenotype of transthyretin cardiac amyloidosis: THAOS (Transthyretin Amyloid Outcomes Survey)","volume":"68","author":"Maurer","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.autneu.2019.102590_bb0085","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/00004872-199816030-00002","article-title":"Does it matter whether blood pressure measurements are taken with subjects sitting or supine?","volume":"16","author":"Netea","year":"1998","journal-title":"J. Hypertens."},{"key":"10.1016\/j.autneu.2019.102590_bb0090","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1007\/s00415-014-7373-0","article-title":"Update in the diagnosis and management of transthyretin familial amyloid polyneuropathy","volume":"261","author":"Plante-Bordeneuve","year":"2014","journal-title":"J. Neurol."},{"key":"10.1016\/j.autneu.2019.102590_bb0095","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/S1474-4422(11)70246-0","article-title":"Familial amyloid polyneuropathy","volume":"10","author":"Plante-Bordeneuve","year":"2011","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.autneu.2019.102590_bb0100","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1185\/03007995.2012.754349","article-title":"The Transthyretin Amyloidosis Outcomes Survey (THAOS) registry: design and methodology","volume":"29","author":"Plante-Bordeneuve","year":"2013","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.autneu.2019.102590_bb0105","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1093\/eurheartj\/ehs123","article-title":"Disease profile and differential diagnosis of hereditary transthyretin-related amyloidosis with exclusively cardiac phenotype: an Italian perspective","volume":"34","author":"Rapezzi","year":"2013","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.autneu.2019.102590_bb0110","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.amjhyper.2004.09.006","article-title":"What is the accuracy of clinic blood pressure measurement?","volume":"18","author":"Sala","year":"2005","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.autneu.2019.102590_bb0115","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/jns5.12059","article-title":"Norfolk QOL-DN: validation of a patient reported outcome measure in transthyretin familial amyloid polyneuropathy","volume":"19","author":"Vinik","year":"2014","journal-title":"J. Peripher. Nerv. Syst."}],"container-title":["Autonomic Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1566070219301043?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1566070219301043?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T12:12:44Z","timestamp":1761567164000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1566070219301043"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":23,"alternative-id":["S1566070219301043"],"URL":"https:\/\/doi.org\/10.1016\/j.autneu.2019.102590","relation":{},"ISSN":["1566-0702"],"issn-type":[{"value":"1566-0702","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Blood pressure and orthostatic hypotension as measures of autonomic dysfunction in patients from the transthyretin amyloidosis outcomes survey (THAOS)","name":"articletitle","label":"Article Title"},{"value":"Autonomic Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autneu.2019.102590","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"102590"}}